EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Advances in Cardioprotection Strategies: Focusing on Breast Cancer and Beyond Through Novel Biomarkers and Pharmacological Approaches

Giulia Tamburrini, Celia de Cobos García, Teresa López-Fernández

European Cardiology Review · 09.09.2025 · 20

DOI: 10.15420/ecr.2025.26 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Cardiology Review, online erschienen am 09.09.2025. Verfasst von Giulia Tamburrini und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Policlinico Gemelli Rome, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent improvements in cancer treatments have significantly improved patient survival rates, which has drawn attention to cardiovascular complications that may arise after using oncological therapies. These complications can seriously affect quality of life and long-term outcomes, sometimes leading to the need for modification or discontinuation of cancer treatment. This highlights the urgent need for effective cardioprotective strategies to prevent and mitigate clinical and subclinical cardiotoxicity, as well as reducing acute and chronic cardiac damage. In this review, we critically evaluate the cardiac biomarkers used in clinical practice for early detection and monitoring of cardiotoxicity, focusing on N-terminal pro-B-type natriuretic peptide and troponins due to their established predictive value. We also explore emerging biomarkers that may improve cardiovascular risk assessment in cancer patients. On the pharmacological front, β-blockers, angiotensin-converting enzyme inhibitors and sodium–glucose cotransporter 2 inhibitors show potential for mitigating cardiotoxicity, although evidence from randomised trials remains mixed. Non-pharmacological approaches are also discussed, and the aim is to integrate comprehensive cardiovascular prevention into oncology care.

Schlagwörter

Stichwörter der Autor:innen

Breast cancercardiac biomarkerscardio-oncologycardioprotectionchemotherapy-induced cardiotoxicityheart failure

Autor:innen und Institutionen

  • Cardiology Department, Policlinico Gemelli Rome, Italy.
  • Oncology Department, La Paz University Hospital Madrid, Spain.
  • Cardiology Department, La Paz University Hospital Madrid, Spain.
  • Hospital La Paz Institute for Health Research Madrid, Spain.

Zitieren

APA

Tamburrini, G., de Cobos García, C., & López-Fernández, T. (2025). Advances in Cardioprotection Strategies: Focusing on Breast Cancer and Beyond Through Novel Biomarkers and Pharmacological Approaches. European Cardiology Review, 20. https://doi.org/10.15420/ecr.2025.26

Vancouver

Tamburrini G, de Cobos García C, López-Fernández T. Advances in Cardioprotection Strategies: Focusing on Breast Cancer and Beyond Through Novel Biomarkers and Pharmacological Approaches. European Cardiology Review. 2025;20. doi:10.15420/ecr.2025.26

BibTeX
@article{Tamburrini2025,
  author = {Tamburrini, Giulia and de Cobos García, Celia and López-Fernández, Teresa},
  title = {Advances in Cardioprotection Strategies: Focusing on Breast Cancer and Beyond Through Novel Biomarkers and Pharmacological Approaches},
  journal = {European Cardiology Review},
  year = {2025},
  volume = {20},
  doi = {10.15420/ecr.2025.26}
}
Kostenlos starten →